ScholarIQanswers from OpenAlex & ORCID
Paul A. Bunn
ResearcherPublications, citations & collaboration network
Paul A. Bunn is a researcher indexed in ScholarIQ from OpenAlex & ORCID.
How many works does Paul A. Bunn have?
ScholarIQindexed works
Paul A. Bunn has 886 works in the ScholarIQ index. The count is the OpenAlex total, not the number of papers listed on this page.
How many citations does Paul A. Bunn have?
ScholarIQcitation count
Paul A. Bunn has 52,357 citations in the OpenAlex counts ScholarIQ stores.
What is the h-index of Paul A. Bunn?
ScholarIQh-index
Paul A. Bunn has an h-index of 115 in OpenAlex.
What is the i10-index of Paul A. Bunn?
ScholarIQi10-index
Paul A. Bunn has an i10-index of 375 in OpenAlex.
What is the ORCID of Paul A. Bunn?
ScholarIQorcid
The ORCID for Paul A. Bunn is on the source record.
What is the OpenAlex record for Paul A. Bunn?
ScholarIQopenalex
The OpenAlex for Paul A. Bunn is on the source record.
What are the most-cited papers on Paul A. Bunn?
ScholarIQmost cited works
Randomized Phase III Trial of Pemetrexed Versus Docetaxel in Patients With Non–Small-Cell Lung Cancer Previously Treated With Chemotherapy
Nasser H. Hanna, Frances A. Shepherd, Frank V. Fossella, Jose R. Pereira, Filippo de Marinis, Joachim von Pawel, U. Gatzemeier, Thomas Chang Yao Tsao, Miklos Pless, Thomas Müller, Hong-Liang Lim, Christopher E. Desch, Klára Szondy, Radj Gervais, Shaharyar, Christian Manegold, Sofia Paul, Paolo Paoletti, Lawrence Einhorn, Paul A. Bunn
Using Multiplexed Assays of Oncogenic Drivers in Lung Cancers to Select Targeted Drugs
Mark G. Kris, Bruce E. Johnson, Lynne D. Berry, David J. Kwiatkowski, A. John Iafrate, Ignacio I. Wistuba, Marileila Varella‐Garcia, Wilbur A. Franklin, Samuel L. Aronson, Pei-Fang Su, Yu Shyr, D. Ross Camidge, Lecia V. Sequist, Bonnie S. Glisson, Fadlo R. Khuri, Edward B. Garon, William Pao, Charles M. Rudin, Joan H. Schiller, Eric B. Haura, Mark A. Socinski, Keisuke Shirai, Heidi Chen, Giuseppe Giaccone, Marc Ladanyi, Kelly Kugler, John D. Minna, Paul A. Bunn
IASLC Multidisciplinary Recommendations for Pathologic Assessment of Lung Cancer Resection Specimens After Neoadjuvant Therapy
William D. Travis, Sanja Đačić, Ignacio I. Wistuba, Lynette M. Sholl, Prasad S. Adusumilli, Lukas Bubendorf, Paul A. Bunn, Tina Cascone, Jamie E. Chaft, Gang Chen, Teh‐Ying Chou, Wendy A. Cooper, Jeremy J. Erasmus, Carlos Gil Ferreira, Jin-Mo Goo, John V. Heymach, Fred R. Hirsch, Hidehito Horinouchi, Keith M. Kerr, Mark G. Kris, Deepali Jain, Young Tae Kim, Fernando López‐Ríos, Shun Lü, Tetsuya Mitsudomi, André Moreira, Noriko Motoi, Andrew G. Nicholson, Ricardo Oliveira, Mauro Papotti, Ugo Pastorino, Luis Paz‐Ares, Giuseppe Pelosi, Claudia Poleri, Mariano Provencio, Anja C. Roden, Giorgio V. Scagliotti, Stephen G. Swisher, Erik Thunnissen, Ming‐Sound Tsao, Johan Vansteenkiste, Walter Weder, Yasushi Yatabe
HER2 exon 20 insertions in non-small-cell lung cancer are sensitive to the irreversible pan-HER receptor tyrosine kinase inhibitor pyrotinib
Y. Wang, Tao Jiang, Zhen Qin, Jinghui Jiang, Qiang Wang, Seung Hee Yang, Christopher J. Rivard, G. Gao, T L Ng, Megan M. Tu, Hui Yu, Huiping Ji, Caicun Zhou, Shengxiang Ren, Jun Zhang, Paul A. Bunn, Robert C. Doebele, D. Ross Camidge, Fred R. Hirsch